Maha Farhat holds an MD from the McGill University Faculty of Medicine and a MSc in biostatistics from the Harvard Chan School of Public Health. She is also a practicing physician at the Massachusetts General Hospital Division of Pulmonary and Critical Care Medicine.
Dr. Farhat's research focuses on the development and application of methods for associating genotype and phenotype in infectious disease pathogens, with a strong emphasis on translation to better diagnostics and surveillance in resource-poor settings. To date, Farhat's work has focused on the pathogen Mycobacterium tuberculosis and spans the spectrum from computational analysis to field studies. She is PI and Co-Investigator on several large projects funded by NIH including the NIAID and the BD2K initiative.
American journal of respiratory and critical care medicine, September 1, 2016
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, August 1, 2016
Journal of clinical microbiology, January 13, 2016
American journal of surgery, October 24, 2015
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, March 1, 2015
Genome medicine, November 15, 2014
The Journal of antimicrobial chemotherapy, September 20, 2013
Nature genetics, September 1, 2013
The European respiratory journal, June 1, 2013
Critical care (London, England), February 25, 2011